[Federal Register Volume 60, Number 204 (Monday, October 23, 1995)]
[Notices]
[Page 54387]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-26089]



=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on September 19, 1995, Norac 
Company, Inc., 405 S. Motor Avenue, Azusa, California 91702, made 
application to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of the Schedule I controlled 
substance Tetrahydrocannabinols (7370).
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application.
    The firm plans to manufacture medication for the treatment of AIDS 
wasting syndrome and as an antiemetic.
    Any such comments or objections may be addressed to the Deputy 
Assistant Administrator, Office of Diversion Control, Drug Enforcement 
Administration, United States Department of Justice, Washington, D.C. 
20537, Attention: DEA Federal Register Representative (CCR), and must 
be filed no later than December 22, 1995.

    Dated: October 16, 1995.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 95-26089 Filed 10-20-95; 8:45 am]
BILLING CODE 4410-09-M